SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-005351
Filing Date
2024-01-22
Accepted
2024-01-22 06:10:03
Documents
18
Period of Report
2024-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243774d1_8k.htm   iXBRL 8-K 33251
2 EXHIBIT 1.1 tm243774d1_ex1-1.htm EX-1.1 266924
3 EXHIBIT 5.1 tm243774d1_ex5-1.htm EX-5.1 7617
4 EXHIBIT 99.1 tm243774d1_ex99-1.htm EX-99.1 9209
5 EXHIBIT 99.2 tm243774d1_ex99-2.htm EX-99.2 9302
9 GRAPHIC tm243774d1_ex99-1img001.jpg GRAPHIC 4235
10 GRAPHIC tm243774d1_ex99-2img002.jpg GRAPHIC 4328
  Complete submission text file 0001104659-24-005351.txt   589914

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA espr-20240118.xsd EX-101.SCH 3015
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20240118_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20240118_pre.xml EX-101.PRE 22359
12 EXTRACTED XBRL INSTANCE DOCUMENT tm243774d1_8k_htm.xml XML 3329
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 24547028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)